HK1006365A1 - Hcg liquid formulations - Google Patents
Hcg liquid formulationsInfo
- Publication number
- HK1006365A1 HK1006365A1 HK98105724A HK98105724A HK1006365A1 HK 1006365 A1 HK1006365 A1 HK 1006365A1 HK 98105724 A HK98105724 A HK 98105724A HK 98105724 A HK98105724 A HK 98105724A HK 1006365 A1 HK1006365 A1 HK 1006365A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- hcg
- soln
- liquid formulations
- polyalcohol
- mannitol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Pregnancy & Childbirth (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gynecology & Obstetrics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polyurethanes Or Polyureas (AREA)
- Cosmetics (AREA)
- Semiconductor Memories (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP1995/001055 WO1996029095A1 (en) | 1995-03-21 | 1995-03-21 | Hcg liquid formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1006365A1 true HK1006365A1 (en) | 1999-02-26 |
Family
ID=8165977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98105724A HK1006365A1 (en) | 1995-03-21 | 1998-06-19 | Hcg liquid formulations |
Country Status (16)
Country | Link |
---|---|
US (1) | US6706681B1 (ja) |
EP (1) | EP0814841B1 (ja) |
JP (1) | JP4165718B2 (ja) |
KR (1) | KR100377967B1 (ja) |
AT (1) | ATE209930T1 (ja) |
AU (1) | AU707796B2 (ja) |
BR (1) | BR9510567A (ja) |
DE (1) | DE69524456T2 (ja) |
DK (1) | DK0814841T3 (ja) |
ES (1) | ES2166841T3 (ja) |
FI (1) | FI117160B (ja) |
HK (1) | HK1006365A1 (ja) |
NO (1) | NO318997B1 (ja) |
PT (1) | PT814841E (ja) |
UA (1) | UA61053C2 (ja) |
WO (1) | WO1996029095A1 (ja) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6319504B1 (en) | 1996-06-24 | 2001-11-20 | University Of Maryland Biotechnology Institute | Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin |
TW518235B (en) * | 1997-01-15 | 2003-01-21 | Akzo Nobel Nv | A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage |
EP0972520B9 (en) * | 1997-01-30 | 2006-03-22 | Biopharm Gesellschaft zur biotechnologischen Entwicklung von Pharmaka mbH | Freeze-dried composition of bone morphogenetic protein human mp52 |
ES2307585T3 (es) | 2000-02-22 | 2008-12-01 | Laboratoires Serono Sa | Procedimiento para purificar hcg recombinante que tiene una bioactividad especifica. |
JP5490972B2 (ja) * | 2000-08-04 | 2014-05-14 | 中外製薬株式会社 | タンパク質注射製剤 |
FR2869979B1 (fr) * | 2004-05-06 | 2006-08-04 | Packinox Sa | Echangeur thermique a plaques |
KR101105871B1 (ko) * | 2005-09-27 | 2012-01-16 | 주식회사 엘지생명과학 | 인 난포자극호르몬의 안정한 용액 제형 |
KR20080106636A (ko) * | 2007-06-04 | 2008-12-09 | 동아제약주식회사 | 사람 융모성 성선자극호르몬 함유 즉시 사용형 주사 용액 |
JP5551601B2 (ja) * | 2007-11-01 | 2014-07-16 | メルク セローノ ソシエテ アノニム | Lh液体調製物 |
TWI532495B (zh) * | 2009-10-05 | 2016-05-11 | 菲瑞茵國際中心股份有限公司 | 藥學製劑 |
WO2011108010A2 (en) * | 2010-03-05 | 2011-09-09 | Intas Biopharmaceuticals Limited | A thermostable liquid formulation of gonadotropins |
EP2417982A1 (en) | 2010-07-30 | 2012-02-15 | Ferring B.V. | Stabilization of gonadotropins |
US8680086B2 (en) | 2011-04-15 | 2014-03-25 | Neuralight Hd, Llc | Methods for chronic pain management and treatment using HCG |
US20120265129A1 (en) | 2011-04-15 | 2012-10-18 | Neuralight Hd, Llc | Methods for Chronic Pain Management and Treatment using HCG |
BR112015008753A2 (pt) | 2012-10-18 | 2017-07-04 | Neuralight Hd Llc | tratamento de depressão e ptsd |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL88233A (en) * | 1987-11-03 | 1993-08-18 | Genentech Inc | Gamma interferon formulation |
IE64738B1 (en) * | 1990-03-20 | 1995-09-06 | Akzo Nv | Stabilized gonadotropin containing preparations |
US5385230A (en) * | 1991-01-11 | 1995-01-31 | Minnesota Mining And Manufacturing Company | Adjustable tray assembly for use in desk drawers |
JP2966592B2 (ja) * | 1991-07-20 | 1999-10-25 | 萩原 義秀 | 安定化されたヒトモノクローナル抗体製剤 |
IT1250075B (it) * | 1991-12-18 | 1995-03-30 | Serono Cesare Ist Ricerca | Composizioni farmaceutiche contenenti gonadotropine. |
-
1995
- 1995-03-21 BR BR9510567A patent/BR9510567A/pt not_active IP Right Cessation
- 1995-03-21 DE DE69524456T patent/DE69524456T2/de not_active Expired - Lifetime
- 1995-03-21 UA UA97105098A patent/UA61053C2/uk unknown
- 1995-03-21 JP JP52800396A patent/JP4165718B2/ja not_active Expired - Lifetime
- 1995-03-21 WO PCT/EP1995/001055 patent/WO1996029095A1/en active IP Right Grant
- 1995-03-21 DK DK95944848T patent/DK0814841T3/da active
- 1995-03-21 AT AT95944848T patent/ATE209930T1/de active
- 1995-03-21 ES ES95944848T patent/ES2166841T3/es not_active Expired - Lifetime
- 1995-03-21 KR KR1019970706266A patent/KR100377967B1/ko not_active IP Right Cessation
- 1995-03-21 PT PT95944848T patent/PT814841E/pt unknown
- 1995-03-21 EP EP95944848A patent/EP0814841B1/en not_active Expired - Lifetime
- 1995-03-21 AU AU21106/95A patent/AU707796B2/en not_active Expired
-
1997
- 1997-03-21 US US08/913,748 patent/US6706681B1/en not_active Expired - Lifetime
- 1997-09-18 NO NO19974309A patent/NO318997B1/no not_active IP Right Cessation
- 1997-09-22 FI FI973745A patent/FI117160B/fi not_active IP Right Cessation
-
1998
- 1998-06-19 HK HK98105724A patent/HK1006365A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU707796B2 (en) | 1999-07-22 |
DE69524456T2 (de) | 2002-08-01 |
FI117160B (fi) | 2006-07-14 |
DE69524456D1 (de) | 2002-01-17 |
KR19980702859A (ko) | 1998-08-05 |
NO974309D0 (no) | 1997-09-18 |
AU2110695A (en) | 1996-10-08 |
JPH11502205A (ja) | 1999-02-23 |
FI973745A0 (fi) | 1997-09-22 |
FI973745A (fi) | 1997-11-11 |
ATE209930T1 (de) | 2001-12-15 |
UA61053C2 (en) | 2003-11-17 |
NO318997B1 (no) | 2005-05-30 |
EP0814841B1 (en) | 2001-12-05 |
BR9510567A (pt) | 1998-06-23 |
EP0814841A2 (en) | 1998-01-07 |
DK0814841T3 (da) | 2002-03-04 |
WO1996029095A1 (en) | 1996-09-26 |
JP4165718B2 (ja) | 2008-10-15 |
NO974309L (no) | 1997-10-14 |
KR100377967B1 (ko) | 2003-06-12 |
ES2166841T3 (es) | 2002-05-01 |
PT814841E (pt) | 2002-03-28 |
US6706681B1 (en) | 2004-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1006365A1 (en) | Hcg liquid formulations | |
EP0803796A3 (en) | Display control system with drive signal locking for a non activated optional CRT display | |
IL133220A0 (en) | Stabilized antibody formulation | |
ITMI930578A0 (it) | Metodo e dispositivo per salvare un'immagine di sitema su una memoria permanate, in modo indipendente dal sistema operativo | |
ZA9610535B (en) | Antagonists of gonadotropin releasing hormone. | |
ZA9610536B (en) | Antagonists of gonadotropin releasing hormone. | |
AU8490091A (en) | Construction and process for producing the same, associated construction elements and sets of construction elements | |
FR2690147B1 (fr) | Plate-forme, notamment pour cabine d'ascenseur et monte-charge, en materiau composite. | |
IL122981A (en) | R-n-¬1- ¬2-¬1-¬ 4-5- (2,3-dihydro ¬1,4¾ benzodioxinyl) piperazinyl¾ propyl¾-n- (2-pyridyl)- cyclohexane carboxamide methods for its preparation and pharmaceutical compositions containing it | |
EP0888777A3 (en) | Recombinant bovine herpesvirus type 1 polyptpetides and vaccines | |
WO2000072820A3 (en) | Injectable anesthetic formulation | |
AU4480993A (en) | Polydimethylsiloxanes for modulus reduction and method for their preparation | |
EP0764446A3 (en) | An adjuvanted vaccine which is substantially free of non-host albumin | |
PL321736A1 (en) | Bar joint | |
FR2717760B1 (fr) | Dispositif de réduction de la trainée aerodynamique d'une cavité dans un écoulement et véhicule, notamment ferroviaire, comprenant un tel dispositif. | |
EP0599200A3 (en) | Solid-state imaging device and method for its operation. | |
AU4964197A (en) | Recombinant single-stranded equine chorionic gonadotropin | |
WO1997026867A3 (de) | Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung | |
Hunter | Modern and ancient coral associations of the Cayman Islands | |
Pleydell | Aspects of diagenesis and ichnology in the Olioocene-Miocene Bluff Formation of Grand Cayman Island, British West Indies | |
AU2001258638A1 (en) | Methods for identifying modulators of the interaction between lap (latency associated peptide) and intergrin alpha.v.beta.3 and medical use thereof | |
MX9707121A (es) | Formulaciones liquidas de gch. | |
FR2700019B3 (fr) | Procédé et dispositif de contrôle d'injections dans le sol. | |
Motrya et al. | Physical-chemical investigation of the systems HgS-SnS, HgS-SnS sub 2 | |
Singaravélou | Wink, A.-Al Hind. The Making of the Indo-Islamic World. Vol. I. Early medieval India and the expansion of Islam 7-1 1 th Centuries, 1990 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHPA | Change of a particular in the register (except of change of ownership) | ||
PF | Patent in force | ||
PE | Patent expired |
Effective date: 20150320 |